RU2016136902A - A method for predicting the development of pulmonary embolism in cancer patients with phlebothrombosis of the lower extremities - Google Patents

A method for predicting the development of pulmonary embolism in cancer patients with phlebothrombosis of the lower extremities Download PDF

Info

Publication number
RU2016136902A
RU2016136902A RU2016136902A RU2016136902A RU2016136902A RU 2016136902 A RU2016136902 A RU 2016136902A RU 2016136902 A RU2016136902 A RU 2016136902A RU 2016136902 A RU2016136902 A RU 2016136902A RU 2016136902 A RU2016136902 A RU 2016136902A
Authority
RU
Russia
Prior art keywords
development
pulmonary embolism
phlebothrombosis
predicting
cancer patients
Prior art date
Application number
RU2016136902A
Other languages
Russian (ru)
Other versions
RU2016136902A3 (en
RU2664448C2 (en
Inventor
Олег Иванович Кит
Оксана Васильевна Кательницкая
Original Assignee
Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации filed Critical Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации
Priority to RU2016136902A priority Critical patent/RU2664448C2/en
Publication of RU2016136902A3 publication Critical patent/RU2016136902A3/ru
Publication of RU2016136902A publication Critical patent/RU2016136902A/en
Application granted granted Critical
Publication of RU2664448C2 publication Critical patent/RU2664448C2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Claims (1)

Способ прогнозирования развития тромбоэмболии легочной артерии у онкологических больных с флеботромбозом нижних конечностей, заключающийся в том, что при развитии венозного тромбоза в системе нижней полой вены, до начала антикоагулянтной терапии, определяют исходный количественный показатель D-димера и при уровне последнего выше 2,88 нг/мл прогнозируют развитие тромбоэмболии легочной артерии.A method for predicting the development of pulmonary embolism in cancer patients with phlebothrombosis of the lower extremities, which consists in the fact that, with the development of venous thrombosis in the system of the inferior vena cava, before starting anticoagulant therapy, the initial quantitative indicator of D-dimer is determined and at a level of the latter above 2.88 ng / ml predict the development of pulmonary embolism.
RU2016136902A 2016-09-14 2016-09-14 Method for predicting pulmonary arterial embolization in oncology patients with lower extremity phlebothrombosis RU2664448C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2016136902A RU2664448C2 (en) 2016-09-14 2016-09-14 Method for predicting pulmonary arterial embolization in oncology patients with lower extremity phlebothrombosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2016136902A RU2664448C2 (en) 2016-09-14 2016-09-14 Method for predicting pulmonary arterial embolization in oncology patients with lower extremity phlebothrombosis

Publications (3)

Publication Number Publication Date
RU2016136902A3 RU2016136902A3 (en) 2018-03-19
RU2016136902A true RU2016136902A (en) 2018-03-19
RU2664448C2 RU2664448C2 (en) 2018-08-17

Family

ID=61627321

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016136902A RU2664448C2 (en) 2016-09-14 2016-09-14 Method for predicting pulmonary arterial embolization in oncology patients with lower extremity phlebothrombosis

Country Status (1)

Country Link
RU (1) RU2664448C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2767140C1 (en) * 2021-03-22 2022-03-16 Нур Гасымович Сибагатуллин Method for quantifying the massiveness of pulmonary embolism

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2522398C1 (en) * 2013-01-28 2014-07-10 федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Хакасский государственный университет им. Н.Ф. Катанова" (ФГБОУ ВПО "ХГУ им. Н.Ф. Катанова") Method for prediction of risk of developing pulmonary artery thromboembolia in patients with deep venous thrombosis

Also Published As

Publication number Publication date
RU2016136902A3 (en) 2018-03-19
RU2664448C2 (en) 2018-08-17

Similar Documents

Publication Publication Date Title
EA201890453A1 (en) ANTI-ANGPTL8 ANTIBODIES AND THEIR APPLICATION
DK3185854T3 (en) INJECTIBLE SUSPENSIONS AND METHODS FOR THE MANUFACTURE AND USE OF THESE
CL2015001941A1 (en) Anti-il-17a antibodies and their use in the treatment of autoimmune and inflammatory disorders.
MA43660A (en) ANTI-COAGULATION FACTOR XI ANTIBODY
MX2016009060A (en) Methods and systems for determining risk of heart failure.
MA40552A (en) PYRIMIDINE DERIVATIVES POSSIBLY CONDENSED SUBSTITUTED BY A HETEROCYCLE USEFUL IN THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGICAL AND AUTOIMMUNE DISEASES
DK3355919T3 (en) COMBINATION THERAPY USING HUMAN GROWTH AND DIFFERENTIATION FACTOR 15 (GDF-15) INHIBITORS AND IMMUNE CHECKPOINT BLOCKERS
MA45234A (en) ANTI-COAGULATION FACTOR XI ANTIBODY
MX2017004742A (en) Methods for prediction of anti-tnf alpha drug levels and autoantibody formation.
MA44777A (en) HUMANIZED ANTI-BASIGIN ANTIBODIES AND THEIR USE
MA42546A (en) BRUTON TYROSINE KINASE INHIBITOR COMBINATIONS AND THEIR USES
RU2016136902A (en) A method for predicting the development of pulmonary embolism in cancer patients with phlebothrombosis of the lower extremities
EA202090673A1 (en) STRATIFICATION OF THE GENOTYPE IN THE TREATMENT AND PREVENTION OF DIABETES
FR3024237B1 (en) METHOD OF DETERMINING THE STRUCTURAL PROFILE OF A FIBRIN FOOTBALL, REFLECTING ITS STABILITY, TO PREDICT THE RISK OF BLEEDING, THROMBOSIS OR RE-THROMBOSIS
MA41908A (en) ANTI-FLT-1 ANTIBODIES USED IN THE TREATMENT OF BRONCHOPULMONARY DYSPLASIA
DK3201555T3 (en) SYSTEM AND PROCEDURE FOR DETERMINING THE CHARGING LEVEL IN A LATENT HEAT STORE
DK3729097T3 (en) Methods based on the detection of Rad51 foci in tumor cells
DK3631472T3 (en) METHODS OF DIAGNOSING AND TREATMENT OF CHRONIC KIDNEY DISEASE
FR3045071B1 (en) RAPID PREDICTIVE METHOD FOR CHARACTERIZING THE RADIOSENSITIVITY OF A PATIENT TO IRRADIATION WITH IONIZING RADIATION
RU2015138264A (en) A method for predicting the risk of normotensive glaucoma
RU2014140351A (en) A method for the prevention of massive pulmonary thromboembolism in patients with venous thrombosis
JP2015521041A5 (en)
RU2015128668A (en) A method for predicting the course of tuberculosis
EA201990903A1 (en) METHOD FOR REDUCING PROTEINURIA IN A HUMAN SUFFERING FROM IMMUNOGLOBULIN AND NEPHROPATHY
FR3051537B1 (en) DIOPTER RECTIFIER

Legal Events

Date Code Title Description
HC9A Changing information about author(s)
MM4A The patent is invalid due to non-payment of fees

Effective date: 20180915